SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

28 Jan 2025 Evaluate
The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 112.40 millions.The Company to register a -49.60%  fall in the net profit for the quarter ended December 2024.Operating Profit reported a sharp decline to 42.46 millions from 55.48 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 112.40 109.42 2.72 309.17 317.26 -2.55 408.34 424.24 -3.75
Other Income 3.74 2.84 31.69 10.55 6.78 55.60 10.04 10.84 -7.38
PBIDT 42.46 55.48 -23.47 107.68 151.19 -28.78 182.26 217.87 -16.34
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.12 0.00
PBDT 48.70 55.48 -12.22 127.40 151.19 -15.74 182.26 216.75 -15.91
Depreciation 17.60 17.44 0.92 52.33 53.52 -2.22 70.85 71.73 -1.23
PBT 31.10 38.04 -18.24 75.07 97.67 -23.14 111.41 145.02 -23.18
TAX 14.16 4.43 219.64 31.75 21.29 49.13 28.43 29.17 -2.54
Deferred Tax 14.16 4.43 219.64 31.75 21.29 49.13 28.43 29.17 -2.54
PAT 16.94 33.61 -49.60 43.32 76.38 -43.28 82.98 115.85 -28.37
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 37.78 50.70 -25.50 34.83 47.65 -26.91 44.63 51.36 -13.09

Zenotech Laboratorie Share Price

47.24 -2.15 (-4.35%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×